Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for QHSLab Inc. (USAQ : OTC)
 
 • Company Description   
QHSLab, Inc. is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. Digital healthcare allows doctors to remotely monitor patients' vital signs and evaluate the effects of prescribed medicines and treatments on patients' health through real-time data transferred from patient to doctor. The company also markets and sells point-of-care, rapid-response diagnostic tests used in the primary care practice. The company changed its name to QHSLab from USA Equities Corp. in April 2022.

Number of Employees: 5

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.40 Daily Weekly Monthly
20 Day Moving Average: 5,090 shares
Shares Outstanding: 8.76 (millions)
Market Capitalization: $3.50 (millions)
Beta: -1.47
52 Week High: $1.00
52 Week Low: $0.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -27.22% -18.04%
12 Week -11.09% -2.26%
Year To Date -45.18% -43.26%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
901 NORTHPOINT PARKWAY SUITE 302
-
WEST PALM BEACH,FL 33407
USA
ph: 929-379-6503
fax: -
ir@usaqcorp.com http://www.usaqcorp.com
 
 • General Corporate Information   
Officers
Troy Grogan - Chief Executive Officer; Chief Financial Officer
Troy Grogan - Chief Financial Officer
- - -
- - -
- - -

Peer Information
QHSLab Inc. (CORR.)
QHSLab Inc. (RSPI)
QHSLab Inc. (CGXP)
QHSLab Inc. (BGEN)
QHSLab Inc. (GTBP)
QHSLab Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 90350R107
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 8.76
Most Recent Split Date: 5.00 (0.01:1)
Beta: -1.47
Market Capitalization: $3.50 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.19
Price/Cash Flow: -
Price / Sales: 2.39
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -50.00%
Sales Growth
vs. Year Ago Period: 16.78%
vs. Previous Quarter: 7.58%
ROE
03/31/22 - -0.60
12/31/21 - -0.53
09/30/21 - -0.41
ROA
03/31/22 - -0.14
12/31/21 - -0.13
09/30/21 - -0.10
Current Ratio
03/31/22 - 0.38
12/31/21 - 0.51
09/30/21 - 0.82
Quick Ratio
03/31/22 - -
12/31/21 - 0.43
09/30/21 - 0.70
Operating Margin
03/31/22 - -59.57
12/31/21 - -54.39
09/30/21 - -49.03
Net Margin
03/31/22 - -59.57
12/31/21 - -54.39
09/30/21 - -49.03
Pre-Tax Margin
03/31/22 - -59.59
12/31/21 - -54.46
09/30/21 - -49.05
Book Value
03/31/22 - 0.08
12/31/21 - 0.09
09/30/21 - 67.34
Inventory Turnover
03/31/22 - 0.03
12/31/21 - 0.03
09/30/21 - 0.03
Debt-to-Equity
03/31/22 - 0.68
12/31/21 - 0.61
09/30/21 - 1.49
Debt-to-Capital
03/31/22 - 40.39
12/31/21 - 37.90
09/30/21 - 59.86
 

Powered by Zacks Investment Research ©